Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells

Por Heinrich B, Goepfert K, Delic M, Galle PR, Moehler M
Publicado em 2013-08-01

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in...

Por Trarbach, T, Moehler, M, Heinemann, V, Köhne, C-H, Przyborek, M, Schulz, C, Sneller, V, Gallant, G, Kanzler, S
Publicado em 2010

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with c...

Por Heinrich, B, Klein, J, Delic, M, Goepfert, K, Engel, V, Geberzahn, L, Lusky, M, Erbs, P, Preville, X, Moehler, M
Publicado no Onco Targets Ther (2017)

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric c...

Por Moehler, M, Eimermacher, A, Siebler, J, Höhler, T, Wein, A, Menges, M, Flieger, D, Junginger, T, Geer, T, Gracien, E, Galle, P R, Heike, M
Publicado em 2005

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

Por Wagner, A D, Buechner-Steudel, P, Moehler, M, Schmalenberg, H, Behrens, R, Fahlke, J, Wein, A, Behl, S, Kuss, O, Kleber, G, Fleig, W E
Publicado em 2009

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

Por Hoehler, T, von Wichert, G, Schimanski, C, Kanzler, S, Moehler, M H, Hinke, A, Seufferlein, T, Siebler, J, Hochhaus, A, Arnold, D, Hallek, M, Hofheinz, R, Hacker, U T
Publicado em 2013

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Por Wimberger, P., Gilet, H., Gonschior, A-K., Heiss, M. M., Moehler, M., Oskay-Oezcelik, G., Al-Batran, S-E., Schmalfeldt, B., Schmittel, A., Schulze, E., Parsons, S. L.
Publicado em 2012

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4

Por Schimanski, C C, Bahre, R, Gockel, I, Müller, A, Frerichs, K, Hörner, V, Teufel, A, Simiantonaki, N, Biesterfeld, S, Wehler, T, Schuler, M, Achenbach, T, Junginger, T, Galle, P R, Moehler, M
Publicado em 2006

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

Por Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Publicado em 2012